| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | WH-4-023 | GDSC1000 | pan-cancer | AAC | -0.015 | 0.8 |
| mRNA | Cisplatin | GDSC1000 | pan-cancer | AAC | -0.01 | 0.8 |
| mRNA | LFM-A13 | GDSC1000 | pan-cancer | AAC | 0.01 | 0.8 |
| mRNA | BMS-754807 | GDSC1000 | pan-cancer | AAC | 0.0097 | 0.8 |
| mRNA | TW 37 | GDSC1000 | pan-cancer | AAC | -0.0094 | 0.8 |
| mRNA | JNJ-26854165 | GDSC1000 | pan-cancer | AAC | -0.0096 | 0.8 |
| mRNA | Vandetanib | CTRPv2 | pan-cancer | AAC | 0.01 | 0.8 |
| mRNA | KIN001-260 | GDSC1000 | pan-cancer | AAC | -0.0088 | 0.8 |
| mRNA | masitinib | GDSC1000 | pan-cancer | AAC | 0.0091 | 0.8 |
| mRNA | SZ4TA2 | CTRPv2 | pan-cancer | AAC | 0.015 | 0.8 |